| 000 | 03321nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 107006 | ||
| 003 | ESmaUEC | ||
| 005 | 20230102113322.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn nnnaamaa | ||
| 008 | 180418s2018 gw | s |||| 0|eng d | ||
| 020 |
_a9783319741642 _9 |
||
| 024 | 7 |
_a10.1007/978-3-319-74164-2 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC |
||
| 050 | 4 | _aRM301.65 2018 EB | |
| 245 | 0 | 0 |
_aTargeting Trafficking in Drug Development _cedited by Alfredo Ulloa-Aguirre, Ya-Xiong Tao. |
| 264 | 1 |
_aCham, Switzerland _bSpringer International Publishing _c2018 |
|
| 300 | _a1 recurso en línea (VIII, 425 páginas 57 ilustraciones.) | ||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 347 |
_atext file _bPDF _2 |
||
| 490 | 0 |
_aHandbook of Experimental Pharmacology _x0171-2004 _v245 |
|
| 505 | 0 | _a1. Intracellular trafficking of gonadotropin receptors in health and disease -- 2. Investigating internalization and intracellular trafficking of GPCRs -- 3. Pharmacological chaperones as potential therapeutic strategies for misfolded mutant vasopressin receptors -- 4. Targeting of disordered proteins by small molecules in neurodegenerative diseases -- 5. Pharmacoperones for misfolded gonadotropin receptors -- 6. Pharmacological chaperones: Beyond conformational disorders -- 7. Natural (and unnatural) small molecules as pharmacological chaperones and inhibitors in cancer -- 8. Heritable skeletal disorders arising from defects in processing and transport of Type I procollagen from the ER: perspectives on possible therapeutic approaches -- 9. Conserved oligomeric Golgi and neuronal vesicular trafficking -- 10. SLC6 transporter folding diseases and pharmacochaperoning -- 11. The molecular physiopathogenesis of islet amyloidosis -- 12. Folding defects leading to primary hyperoxaluria -- 13. Potential pharmacological chaperones for cystathionine beta-synthase-deficient homocystinuria. . | |
| 520 | 3 | _aCellular trafficking is only recently identified as a site for therapeutic intervention. This book provides up to date information on the mechanism for exploiting this area for drug development as well as a clear understanding of the individual components of cellular trafficking. The authors are experts in their areas and the book features tables and figures that enable comparison and clear understanding. | |
| 650 | 7 |
_aFarmacología _2embne _9137893 |
|
| 700 | 1 |
_aUlloa-Aguirre, Alfredo. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _0http://id.loc.gov/authorities/names/n2014187062 _1http://viaf.org/viaf/309830565 _9666501 |
|
| 700 | 1 |
_aTao, Ya-Xiong. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _0http://id.loc.gov/authorities/names/nb2010002168 _1http://viaf.org/viaf/106828458 |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9783319741635 |
| 776 | 0 | 8 |
_iEdición impresa: _z9783319741659 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-74164-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 490 | 0 | _aBiomedical and Life Sciences (Springer-11642) | |
| 942 | _2lcc | ||
| 998 |
_aSI _a_alco _a_vill _b07/2019 _cm _dz _ef _feng _ggw _h0 |
||
| 999 |
_c107006 _d107006 _x1 |
||